ARTICLE | Politics, Policy & Law
Still murky, naturally
Patent specialists dissect Supreme Court ruling in Prometheus diagnostics case
March 26, 2012 7:00 AM UTC
The U.S. Supreme Court's ruling in Mayo Collaborative Services et al. v. Prometheus Laboratories Inc. did little to remove uncertainty about what molecular diagnostic claims are patentable under Section 101 of the Patent Act.
By a 9-0 vote last week, the high court struck down Prometheus' diagnostic patents but gave no guidance on what would have made the claims patentable...